about
Fludarabine in the treatment of chronic lymphocytic leukemia: a reviewThe intracellular localization of deoxycytidine kinaseIn vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsNon-myeloablative stem cell transplants.Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapyRole of fludarabine in hematological malignancies.Parallel solution-phase synthesis of an adenosine antibiotic analog library.Clofarabine for the treatment of adult acute myeloid leukemia.Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.Intracellular disposition of fludarabine triphosphate in human natural killer cells.ABC transporters and their role in nucleoside and nucleotide drug resistance.Transcription inhibition as a therapeutic target for cancerFludarabine inhibits DNA replication: a rationale for its use in the treatment of acute leukemias.On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment.Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine.Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.Pyrazolo[4,3-e][1,2,4]triazines: purine analogues with electronic absorption in the visible region.
P2860
Q24645173-47C2F257-3296-4EA8-9B99-FB12D3104D36Q28287910-661554D3-9292-4FA1-96C0-AA82586293ECQ33830733-5C5199B4-152F-4B44-A068-80B59205E96FQ34089106-184AAB66-0CF3-4CA0-A870-607A0C8D0A19Q34368734-66853629-2872-4202-9568-EFBCEF3C01D4Q34571439-87D9359D-E8BE-43C2-98E1-36A89340BFD4Q34582301-30CB29CF-B88D-47D8-AEF3-E06F6F9D5E3BQ35009273-B111CD36-CE69-47E0-BD59-A5411ACC0E0FQ35022487-5B046E0A-2E78-4208-ABD7-6908E88CF419Q36006445-02324378-41BF-49CA-82FA-8A41FE3BC1FEQ37111568-7BBABCE5-73AD-451D-BF70-186095140C21Q37979617-C1F92179-AF2E-49F3-B917-9A1FFAA1B2BFQ38161381-A0EF2D3E-AF48-4CF7-A2F7-C8FE6A2A28DCQ40607249-F53B2B37-63DA-4394-A8BC-4AFFB9202F88Q41049811-ADE578E4-D3EB-4287-B9F4-F5B93BB9F735Q41831996-B348CE11-4B67-4608-91BB-7B6B8EFA4BB9Q42822234-983B715F-7B0F-490D-A43D-81666A7B90A2Q44139126-9A0A1BC6-DB42-4FD1-B412-7E337F742271Q45172522-43B979CE-968D-4D62-8491-266FAB770641Q46896653-4FE0D292-2118-42EA-9F73-EA412D5A93D0
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Metabolism and action of purine nucleoside analogs.
@ast
Metabolism and action of purine nucleoside analogs.
@en
type
label
Metabolism and action of purine nucleoside analogs.
@ast
Metabolism and action of purine nucleoside analogs.
@en
prefLabel
Metabolism and action of purine nucleoside analogs.
@ast
Metabolism and action of purine nucleoside analogs.
@en
P1476
Metabolism and action of purine nucleoside analogs.
@en
P2093
Plunkett W
Saunders PP
P304
P356
10.1016/0163-7258(91)90057-S
P577
1991-01-01T00:00:00Z